D. Banach

发表

Substrate Specificities of Caspase Family Proteases*

J. Mankovich, T. Ghayur, R. Talanian, 1997, The Journal of Biological Chemistry.

Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.

Hua Tang, Bo Liu, Gang Liu, 2011, ACS chemical biology.

Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity

D. M. Simons, P. Richardson, J. Mankovich, 2018, The Journal of clinical investigation.

Cleavage of cytoskeletal proteins by caspases during ovarian cell death: evidence that cell-free systems do not always mimic apoptotic events in intact cells

J. Tilly, K. I. Tilly, R. Talanian, 1997, Cell Death and Differentiation.

Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily.

H. Oppermann, E. Ozkaynak, D. Rueger, 1990, The Journal of biological chemistry.

Functional comparison of recombinant acidic mammalian chitinase with enzyme from murine bronchoalveolar lavage.

P. Richardson, J. Mankovich, A. Cherniack, 2011, Protein expression and purification.

Engineering elastic properties into an anti-TNFα monoclonal antibody

D. Ouellette, I. Correia, D. Filoti, 2018 .

CTLA4-Ig–Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function

Xiaoqing Lu, J. Samayoa, R. Goenka, 2021, The Journal of Immunology.

2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode.

J. Mankovich, R. Dixon, D. Borhani, 2010, Bioorganic & medicinal chemistry letters.

Activation of the CPP 32 Protease in Apoptosis Induced by 1-pD-Arabinofuranosylcytosine and Other DNA-Damaging Agents

D. Kufe, R. Talanian, R. Datta, 2002 .

Preparation of an autolysis-resistant interleukin-1 beta converting enzyme mutant.

J. Mankovich, R. Talanian, M. Hackett, 1996, Biochemistry.

Identification and Characterization of ICH-2, a Novel Member of the Interleukin-1β-converting Enzyme Family of Cysteine Proteases (*)

J. Mankovich, T. Ghayur, Ping Li, 1995, The Journal of Biological Chemistry.

Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents.

E. Alnemri, D. Kufe, R. Talanian, 1996, Blood.

Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol*

Christopher M Harris, A. Hobson, D. Ihle, 2014, The Journal of Biological Chemistry.

Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor

R. Dixon, D. Borhani, R. Talanian, 2012, BMC Structural Biology.

Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study

J. Mankovich, T. Xiang, D. Borhani, 2009, BMC Structural Biology.

Creation of a S1P Lyase bacterial surrogate for structure-based drug design.

R. Judge, J. Dinges, C. Hutchins, 2016, Bioorganic & medicinal chemistry letters.

Activation of a CrmA-insensitive, p35-sensitive Pathway in Ionizing Radiation-induced Apoptosis*

Emad S. Alnemri, Ralph R. Weichselbaum, E. Alnemri, 1997, The Journal of Biological Chemistry.

Bioinspired CRISPR-Mediated Cascade Reaction Biosensor for Molecular Detection of HIV Using a Glucose Meter.

Changchun Liu, Xiong Ding, Ziyue Li, 2023, ACS nano.

Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study

J. Mankovich, T. Xiang, D. Borhani, 2009, BMC Structural Biology.